Bionoid Pharma, Inc.
BINPOTCHealthcare
$0.03
$-0.00(-0.00%)
Market Cap$1619838
P/E Ratio—
52W High$0.448
52W Low$0.0162
Bionoid Pharma, Inc. (BINP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BINP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 22.44% | 48.13% | 45.05% | 45.90% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | 35.99% | 5.16% | -78.17% | -105.95% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | 31.26% | 4.10% | -132.20% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.00 | $0.00 | $-0.00 | $-11.88 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.04B | 0.00B |
| EBITDA | $0.00B | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | -11.53% | 13.48% | -129.26% | -96.16% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Bionoid Pharma, Inc. data
About Bionoid Pharma, Inc. (BINP) Income Statement
Bionoid Pharma, Inc. (BINP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, BINP reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
BINP · 4 questionsBionoid Pharma, Inc. (BINP) reported revenue of $0.00B for 2024, down 100.0% year-over-year.
BINP revenueBINP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09